Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-Sectional Study to Test the Feasibility of Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

NCT01415115 is registered in ClinicalTrials.gov with VeraLight, Inc. as lead sponsor.

NCT NCT01415115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01415115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-Sectional Study to Test the Feasibility of Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications
Lead sponsor
VeraLight, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2007
Completion date
August 31, 2011
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes